Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Ophthalmology Retrieve available abstracts of 21 articles: HTML format

Single Articles

August 2025
1. YU CW, Nanji K, Garg A, Zaman M, et al
   The Prevalence of Diabetic Retinopathy in American Indians/Alaska Natives and non-Indigenous Americans: A Systematic Review and Meta-Analysis.
   Ophthalmology. 2025 Aug 13:S0161-6420(25)00513.
   PubMed     Abstract available
   
   
   
2. NANJI K, Grad J, Hatamnejad A, El-Sayes A, et al
   Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
   Ophthalmology. 2025 Aug 11:S0161-6420(25)00483.
   PubMed     Abstract available
   
   
   April 2025
3. ZAIDI Z, Alshaikhsalama A, Alsoudi A, Rahimy E, et al
   Re: Vasu et al.: Risk of glaucoma in non-diabetic patients using a glucagon like peptide-1 receptor agonist (Ophthalmology. 2025 Feb 18:S0161-6420(25)00132-0).
   Ophthalmology. 2025 Apr 22:S0161-6420(25)00184.
   PubMed    
   
   
   March 2025
4. ARMBRUST KR, Ailani S, Berkenstock MK
   Pre-Operative Glycemic Control and Acute Endophthalmitis after Cataract Surgery in US Veterans with Diabetes Mellitus.
   Ophthalmology. 2025 Mar 21:S0161-6420(25)00186.
   PubMed     Abstract available
   
   
   February 2025
5. VASU P, Dorairaj EA, Weinreb RN, Huang AS, et al
   Risk of Glaucoma in Non-Diabetic Patients using a Glucagon Like Peptide-1 Receptor Agonist.
   Ophthalmology. 2025 Feb 18:S0161-6420(25)00132.
   PubMed     Abstract available
   
   
   
6. LOYA A, Hussain ZS, Muayad J, Chauhan MZ, et al
   Risk of Progression of Non-Proliferative to Proliferative Diabetic Retinopathy Following Cataract Surgery.
   Ophthalmology. 2025 Feb 14:S0161-6420(25)00125.
   PubMed     Abstract available
   
   
   
7. LIM JI, Kim SJ, Bailey ST, Kovach JL, et al
   Diabetic Retinopathy Preferred Practice Pattern(R).
   Ophthalmology. 2025 Feb 7:S0161-6420(24)00784.
   PubMed    
   
   
   January 2025
8. VANDERBEEK BL, Yu Y, Cardillo S, Hubbard R, et al
   Twenty year trends in prevalence and incidence of diabetic retinal disease.
   Ophthalmology. 2025 Jan 30:S0161-6420(25)00076.
   PubMed     Abstract available
   
   
   December 2024
9. BAI WH, Bai YC, Wei JC
   Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2024 Aug 23:S0161-6420(24)00515-3).
   Ophthalmology. 2024 Dec 21:S0161-6420(24)00743.
   PubMed    
   
   
   November 2024
10. CHUANG SH, Chang CH
    Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in type 2 diabetes patients (Ophthalmology. Aug 23 2024;doi:10.1016/j.ophtha.2024.08.023).
    Ophthalmology. 2024 Nov 28:S0161-6420(24)00682.
    PubMed    
    
    
    
11. CHOU CC, Pan SY, Sheen YJ, Lin JF, et al
    Association between Semaglutide and Non-Arteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Real-World Study.
    Ophthalmology. 2024 Nov 2:S0161-6420(24)00685.
    PubMed     Abstract available
    
    
    October 2024
12. KHODEIRY MM, Perez AM, Chang TC
    Pediatric Diabetic Cataract Variations: Intumescence and Volume Loss.
    Ophthalmology. 2024 Oct 18:S0161-6420(24)00568.
    PubMed    
    
    
    August 2024
13. LUM F
    Re: Chauhan et al.: Association of primary open-angle glaucoma with diabetic retinopathy among patients with type 1 and type 2 diabetes. a large global database study. (Ophthalmology. 2024;131:827-835).
    Ophthalmology. 2024 Aug 29:S0161-6420(24)00460.
    PubMed    
    
    
    
14. MUAYAD J, Loya A, Hussain ZS, Chauhan MZ, et al
    Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.
    Ophthalmology. 2024 Aug 23:S0161-6420(24)00515.
    PubMed     Abstract available
    
    
    
15. CHAUHAN MZ, Elhusseiny AM, Uwaydat SH
    Reply to: Re: Chauhan et al.: Association of Primary Open-Angel Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes.
    Ophthalmology. 2024 Aug 3:S0161-6420(24)00461.
    PubMed    
    
    
    July 2024
16. BAI WH, Bai YC, Wei JC
    Re: Chauhan et al.: Association of primary open-angle glaucoma with diabetic retinopathy among patients with type 1 and type 2 diabetes: a large global database study (Ophthalmology. 2024;131:827-835).
    Ophthalmology. 2024 Jul 25:S0161-6420(24)00389.
    PubMed    
    
    
    
17. YANG S, Liu R, Xin Z, Zhu Z, et al
    Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multi-national cohorts.
    Ophthalmology. 2024 Jul 5:S0161-6420(24)00415.
    PubMed     Abstract available
    
    
    
18. JONAS JB, Bikbov MM, Kazakbaeva GM, Wang YX, et al
    Positive and Negative Associations of Myopia with Ocular Diseases in Population-Based Studies.
    Ophthalmology. 2024 Jul 4:S0161-6420(24)00414.
    PubMed     Abstract available
    
    
    June 2024
19. ZARBIN M, Tabano D, Ahmed A, Amador M, et al
    Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials.
    Ophthalmology. 2024 Jun 7:S0161-6420(24)00320.
    PubMed     Abstract available
    
    
    April 2024
20. WENG CY, Maguire MG, Flaxel CJ, Jain N, et al
    Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
    Ophthalmology. 2024 Apr 11:S0161-6420(24)00156.
    PubMed     Abstract available
    
    
    March 2024
21. NIAZI S, Gnesin F, Thein AS, Andreasen JR, et al
    Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
    Ophthalmology. 2024 Mar 8:S0161-6420(24)00171.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.